Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | HAS | CNA |
|---|---|---|
| Price | $89.30 | $45.79 |
| Change today | ▲ 1.85% | ▲ 2.02% |
| Market cap | $12.60B | $12.39B |
| Return, 3 months | +10.4% | -6.9% |
| Return, year to date | +11.4% | +3.1% |
| Return, 1 year | +22.4% | +8.1% |
| P/E (TTM) | 15.9 | 10.1 |
| P/B | 17.9 | 1.1 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | 3.14% | 4.11% |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | +20.2% | +7.0% |
| Analyst buy share | 82% | 0% |
| RSI (14) | 42 | 27 |
| 30-day volatility | 17.6% | 15.8% |
| Max drawdown, 1 year | -27.3% | -18.1% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | Buy | Sell |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
